Gene Therapy Market Scenario  

Increasing funding for gene therapy research, technological advancements in the field of Gene Therapy and high incidence of cancer and other target diseases are some of the major factors propelling the gene therapy market globally. Furthermore, several initiatives have been undertaken by biopharma companies is also one of the factor propelling the growth of Gene Therapy market. However, the high prices of currently available therapies incentivize therapy is one of the major factor expected to hamper the global growth of the market.

Gene Therapy Market Segmentation

The Gene Therapy market is segmented by vector, indication, delivery method and geography. The vectors studied in the Gene Therapy market are Non-Viral Vectors (Oligonucleotides and Other Non-Viral Vectors), and Viral Vectors (Retroviral Vectors (Gamma-Retroviral Vectors and Lentiviral Vectors), Adeno-Associated Virus Vectors and Other Viral Vectors. Furthermore, various indication of Gene Therapy are Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, Neurological Diseases and Other Indications. Likewise, the delivery method comprises of In Vivo Gene Therapy and Ex Vivo Gene Therapy. Based on Geography, the Gene Therapy Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.

Gene Therapy Market by Geography

Based on geography, the Gene Therapy market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global gene therapy market. Major drivers include high adoption of advanced techniques, strong regulatory framework, higher healthcare expenditure, and availability of skilled professionals. Likewise, the U.S. holds the largest market share owing to factors such as highly developed healthcare infrastructure and presence of centers & institutes engaged in R&D on gene therapies.

Gene Therapy Market Key Players

Some of the major players operating in the global Gene Therapy market includes Agtc (Applied Genetic Technologies Corporation), Amgen, Inc., Anges, Inc., Biogen, Bluebird Bio, Inc., Celgene Corporation (A Bristol-Myers Squibb Company), Cellectis, Dynavax Technologies, Gensight Biologics S.A., Gilead Sciences, Inc., Human Stem Cells Institute, Jazz Pharmaceuticals Plc, Molmed S.P.A., Mustang Bio, Novartis Ag, Orchard Therapeutics Plc, Poseida Therapeutics, Inc., Sangamo Therapeutics, Sarepta Therapeutics, Shanghai Sunway Biotech Co., Ltd., Sibiono Genetech Co., Ltd., Spark Therapeutics, Inc. (A Part Of ‎F. Hoffmann-La Roche) and Uniqure N.V. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.

Gene Therapy Market Report Key Benefits

• The report offers changing market dynamics in the Gene Therapy market, presenting historical, current and projected market size in terms of value (USD Million)
• The report comprises a detailed analysis of the factors that drive and restrict the growth of global Gene Therapy market.
• The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of Gene Therapy
• It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the Gene Therapy market performance
• Key players within the global Gene Therapy market are profiled to understand the competitor scenario.

Research Objectives of Gene Therapy Market Report:

• Analysing the outlook of the market with the recent trends and Porter’s five forces analysis.
• Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period.
• Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects.
• Country-level analysis, integrating the demand and supply forces that are influencing the growth of the Gene Therapy market.
• Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years.
• Comprehensive company profiles, covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players.